| Literature DB >> 29188061 |
Annoor Awadasseid1, Kuugbee Eugene1, Mayada Jamal2, Jie Hou1, Ahmed Musa Hago3, Yaser Gamallat1, Abdo Meyiah1, Djibril Bamba1, Chiwala Gift1, Mohnad Abdalla4, Yufang Ma5, Yi Xin1.
Abstract
Coriolus versicolor (CV) contains high levels of bioactive compounds, including the glucan (1→6)-α-D-glucopyranosyl. However, there is a lack of data regarding the potential effect of this CV glucan (CVG) on the stimulation of cytokine production. The present study evaluated the effect of CVG on the stimulation of cytokine production in sarcoma-180-bearing mice. Mice were treated with three doses of CVG (40, 100 or 200 mg/kg body weight) for nine days, after which serum levels of cytokines, namely interleukin (IL)-2, -4, -6, -10, -17A and interferon (IFN)-α and -γ, were investigated by ELISA. CVG significantly promoted the secretion of IL-2, -4, -6, -10, -17A and IFN-α and -γ at the doses of 100 (P<0.05) and 200 (P<0.01) mg/kg, but not at 40 mg/kg (P>0.05), when compared with cyclophosphamide treatment, as a positive control. Additionally, cytokine production associated with T helper (Th)2 and Th17 cells was enhanced compared with that of Th1 cytokines, and the immunomodulatory function of CVG appeared to be IL-10-dependent. These results demonstrate that CVG may stimulate the production of cytokines and serve as a Th2/IL-10-dependent immunomodulator, and thus has promise in supporting cancer therapies.Entities:
Keywords: Coriolus versicolor; antitumor activity; cytokines; glucan; sarcoma-180
Year: 2017 PMID: 29188061 PMCID: PMC5702959 DOI: 10.3892/br.2017.999
Source DB: PubMed Journal: Biomed Rep ISSN: 2049-9434